Home Newsfeeds Earlier Bloomberg Reported Enbridge Rations Canada Pipeline Space, Adding to Oil Headwinds

News

Earlier Bloomberg Reported Enbridge Rations Canada Pipeline Space, Adding to Oil Headwinds

https://www.bloomberg.com/news/articles/2022-11-21/enbridge-rations-canada-pipeline-space-adding-to-oil-headwinds

byCharles Gross

November 21, 2022

1 minute read

https://www.bloomberg.com/news/articles/2022-11-21/enbridge-rations-canada-pipeline-space-adding-to-oil-headwinds

LiveVox Hires 8×8 And Avaya Industry Veterans To Fuel Continued Expansion

By Happy Mohamed

April 27, 9:18 AM

Bobby Hall to lead Global Channel Sales and Paula Morton appointed VP of Sales Engineering LiveVox (NASDAQ:LVOX), a proven cloud CCaaS platform built to transform contact center performance, today announced the

EGHT

Why Adial Pharmaceuticals Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

October 20, 1:45 PM

Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares jumped 60.2% to $0.5101 after jumping 34% on Thursday.

ADIL

Nordson’s Steps To Diversify Despite Volatility, Margin Boost Initiatives Win Analyst Attention Who Prefers Buying The Dips

By Anusuya Lahiri

February 22, 1:16 PM

KeyBanc analyst Jeffrey Hammond upgraded Nordson Corp (NASDAQ:NDSN) from Sector Weight to Overweight and a $255 price target. Nordson reported Q1 sales…

NDSN

Barclays Maintains Equal-Weight on Colgate-Palmolive, Raises Price Target to $80

By Benzinga Newsdesk

January 3, 9:39 AM

Barclays analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and raises the price target from $75 to $80.

Earlier Bloomberg Reported Enbridge Rations Canada Pipeline Space, Adding to Oil Headwinds

Related Posts

LiveVox Hires 8×8 And Avaya Industry Veterans To Fuel Continued Expansion

Why Adial Pharmaceuticals Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

Nordson’s Steps To Diversify Despite Volatility, Margin Boost Initiatives Win Analyst Attention Who Prefers Buying The Dips

Barclays Maintains Equal-Weight on Colgate-Palmolive, Raises Price Target to $80